LifeStance Health Group Inc (LFST) News & Events

$12.310

+0.010 (+0.08%)At close

LFST News

LifeStance Health Surpasses Q2 Earnings Expectations Driven by Clinician Growth

LifeStance (LFST) Q2 2026 Earnings Call Transcript

LifeStance Health Exceeds Q2 Earnings Expectations with 26% Revenue Growth

DaVita Inc. Q2 2026 Earnings Preview

LifeStance Health Group Reports Strong Q1 Earnings

Ensign Group Acquires Texas Nursing Facilities to Expand Operations

LifeStance Health Group Prices 35M Share Secondary Offering at $8.15

LifeStance Health Group Announces Secondary Stock Offering

LifeStance Health Group Hits New Two-Year High Following Stellar Earnings

LifeStance Health Group Announces Secondary Public Offering

8/10 12:30

LifeStance Stock Rises 13.2% to $12.27

LifeStance is up 13.2%, or $1.43 to $12.27.

8/6 07:01

2026 Consensus Adjusted EBITDA Forecast $215M-$235M

2026 consensus $1.66B. Sees 2026 adjusted EBITDA $215M-$235M.

8/6 07:01

Sees Q3 Adjusted EBITDA of $49M-$59M

Sees Q3 adjusted EBITDA $49M-$59M.

5/7 23:50

JPMorgan Prices Deal at $8.15

The deal priced at low end of $8.15-$8.50 target range. JPMorgan is acting as sole book running manager for the offering.

5/7 17:40

JPMorgan Acts as Sole Book Running Manager for the Offering

JPMorgan is acting as sole book running manager for the offering.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.